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Aims Catheter–tissue contact is critical for effective lesion creation in radiofrequency catheter ablation (RFCA). In amulticen-
tre prospective study, we assessed the effect of direct contact force (CF)measurement on acute procedural parameters
during RFCA of atrial fibrillation (AF).
Methods
and results
A new open-irrigated tip catheter with CF sensing (SmartTouchTM, BiosenseWebster Inc.) was used. All the patients under-
went the first ablation procedure for paroxysmal AF with antral pulmonary vein (PV) isolation, aiming at entry and exit con-
duction block in all PVs. Ninety-five patients were enroled in nine centres and successfully underwent ablation. Overall
procedure time, fluoroscopy time, and ablation time were 138.0+67.0, 14.3+11.2, and 33.8+19.4 min, respectively.
The mean CF value during ablation was 12.2+3.9 g. Force time integral (FTI) analysis showed that patients achieving a
value below the median of 543.0gs required longer procedural (158.0+74.0 vs. 117.0+52.0 min, P ¼ 0.004) and fluoros-
copy (17.5+13.0 vs. 11.0+7.7 min, P¼ 0.007) times as comparedwith those inwhomFTIwas above this value. Patients in
whomthemeanCFduringablationwas.20 grequiredshorterprocedural time(92.0+23.0vs.160.0+67.0 min,P¼ 0.01)
as compared with patients in whom this value was ,10 g. Four groin haematomas were the only complications observed.
Conclusion Contact force during RFCA for PV isolation affects procedural parameters, in particular procedural and fluoroscopy
times, without increasing complications.
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Introduction
Catheter ablation (CA) has become a well-established option for
management of drug refractory atrial fibrillation (AF).1,2 Although
several ablation approaches have been developed, a recent HRS/
EHRA/ECAS Expert Consensus3 recommends ablation strategies
that target the pulmonary veins (PVs) and/or PV antrum as the
cornerstone for most AF ablation procedures, the goal being com-
plete electrical isolation of all PVs. One of the major limitations of
CA of AF is the high rate of recurrences, during the short- and long-
term follow-up, mainly due to electrical reconnection of the PVs.
Therefore, more durable and transmural lesions produced by radio-
frequency energy (RF) are desirable to improve the procedural
outcome.4,5 In this setting, optimization of electrode–tissue
contact may have a two-fold benefit. First, by achieving a satisfactory
contact at the electrode–tissue interface, RF delivery to the tissue is
optimized with less energy dissipated into the circulating blood pool
and creationofmorepredictable and reliable lesions.3 Thismayaffect
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both the procedural parameters and long-term clinical outcome.
Secondly, monitoring the electrode–tissue contact may help
reduce excessive contact and with that the complications possibly
related to cardiac perforation.3
Theaimof thepresentmulticentreprospective studywas toevaluate
theeffectof contact force (CF)measurementonacuteprocedural para-
meters during CA of AF using a novel CF sensing ablation catheter.
Methods
Patients selection
This multicentre prospective and descriptive study enroled patients in
nine Italian centres (see the Appendix) for a 3-month period. Patients
aged between 18 and 90 years with documented symptomatic AF epi-
sodes refractory to drug therapy (Class I or III drugs) and self-terminating
within 7 days were included. Exclusion criteria were: (i) long-standing
persistent AF, defined as AF being the sole rhythm for .12 months
before the enrolment; (ii) persistent AF, defined as non-self-terminating
AF episodes, or self-terminating AF episodes lasting .7 days; (iii) left
atrial (LA) anteroposterior diameter .55 mm; (iv) previous CA of AF;
(v) New York Heart Association functional class .II; (vi) left ventricular
ejection fraction ,40%; (vii) unstable angina or acute myocardial infarc-
tion within 3 months; (viii) need for or prior cardiac surgery within 6
months; (ix) contraindication to treatment with warfarin or bleeding di-
athesis; and (x) severe chronic renal or hepatic impairment.
This study was approved by the institutional review committees of all
centres, and all thepatients signed informedconsents. Theprinciplesout-
lined in the latest update of the Declaration of Helsinki were followed.
Ablation procedure
After transseptal catheterization, three-dimensional electroanatomical
maps of the LA and PVs were reconstructed using a non-fluoroscopic
navigation system (CARTO3w, version 2, BiosenseWebster Inc.) as pre-
viously described.5,6Mapswere acquired duringAFor sinus rhythmusing
respiratory gating. Fast anatomical mapping or imaging integration with a
pre-acquired computed tomography or magnetic resonance scan was
used, according to the operators’ preference. Radiofrequency pulses
were delivered using the 3.5 mm Thermocool SmartTouchTM (Biosense
Webster, Inc.) in power control mode. Radiofrequency power was set
between 30 and 35 W depending on different LA sites and the catheter
tipwas irrigatedby saline at aflowrateof 2 mL/minduringmapping andof
30 mL/min during ablation. Radiofrequency was delivered up to 60 s or
until local electrogram amplitude was reduced .80% to produce a
circumferential lesion around the proximal part of each PV’s ostium or
around ipsilateral PVs according to the anatomy. The lesion around the
PV ostium was created by a sequential point-by-point application of RF
energy or by continuously dragging the catheter, according to the opera-
tors’ preference.A circular decapolaror duodecapolarmapping catheter
(LASSOw, BiosenseWebster Inc.) was used to confirm PV electrical iso-
lation with demonstration of entry and exit block. Resumption of LA to
PV conduction was evaluated for 30 min after ablation. In case of recon-
nection, The PVs were newly isolated targeting the residual electrical
breakthroughs. All centres used fixed curve sheaths (Preface, Biosense
Webster, or SL0, St Jude Medical). In none of the involved centres
were steerable sheaths used.
Contact force measuring
The Thermocool SmartTouchTM catheter is a 7.5 F catheter with a pre-
cision spring connecting the distal 3.5 mm irrigated electrode and the
catheter shaft. The spring allows small amount of tip deflection.
Sensors monitor the location signals of the transmitter coils embedded
in the tip electrode and detect themicromovement of the spring. There-
fore, microdeflections of the tip are translated by the system into CF
values, sampled every 50 ms. Since theprecision spring provides informa-
tiononboth lateral and axialmovements in response to tissue–electrode
contact, direction ofCF is also given. This catheter is specifically designed
for integration into the CARTO3w system.On the system screen, direct
visualization ofCF values averaged on 500 ms time interval (in grams), CF
direction, and instant variations of CF values over time in a real-time
graphic are shown (Figure 1). After catheter insertion and initialization,
the CF value was zeroed for the first time before mapping initiation,
when the catheter tip was in the centre of the LA. During the procedure
the CF value was re-zeroed every time it was required by the system.
Operators involved in this study had previous experience in the use of
Thermocool SmartTouchTM catheter in a 6-month period prior to study
commencement. Since the CF value is a reliable marker of catheter
contact with heart structures, the operators were encouraged to navi-
gate the catheter with a limited use of fluoroscopy. They were allowed
to view in real-time the CF values, during both the mapping and ablation
phase. During RF delivery, it was recommended to make every effort to
reach andmaintain a displayed CF value between 10 and 40 g. According
to previous studies, values in this range proved to be safe and effective.7,8
Forall the ablation sites,CFdatawere recorded andexported after the
procedure for off-line analysis. During each RF application, maximum,
minimum, and mean CT values were stored and subsequently analysed.
Mean CF value were calculated by averaging CF value sampled every
50 ms during each RF application. Force time integral (FTI) expressed
in gram seconds and defined as the integral of the CF-time curve
during the ablation period in which the catheter was located in the
segment of interest was also calculated and analysed.
Statistical analysis
Normally distributed continuous variables were expressed as mean
(+SD) and compared with unpaired Student’s t-test. Skewed variables
were expressed as median (25–75 quartiles) and compared with the
rank-sum test. Normality was assessed by the Shapiro–Wilk test. Cat-
egorical variables were presented as counts and percentages, and com-
pared with x2 test (Pearson, Yates, or Fisher’s exact test as
appropriate). A P value ,0.05 was considered statistically significant.
Results
Study population
Ninety-five patients were included in the study. Their clinical charac-
teristics are shown in Table 1.
What’s new?
† This is the first multicentre experience on a new open-
irrigated tip catheterwith contact forcemeasurement capabil-
ities (SmartTouchTM, Biosense Webster Inc.).
† Contact force during radiofrequency catheter ablation for pul-
monary veins (PVs) isolation affects procedural parameters
reducing significantly procedure and fluoroscopy times,
without increasing acute complications.
† Monitoring of catheter–tissue contact during PVs isolation
shows a significantly longer time of poor contact during abla-
tion of left as compared with that of right PV ablation.
† Contact force parameters were highly variable among differ-
ent patients, while their variability was limited comparing dif-
ferent operators.
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Pulmonary vein isolation and
contact force data
In our study population, image integration was used in 34of 95
patients without any statistically significant influence on procedural
and fluoroscopy time. At the end of the procedure all the target
PVs were persistently isolated. Overall procedural time was
138.0+ 67.0 min with a fluoroscopy time of 14.3+11.2 min. Abla-
tion time was 33.8+ 19.4 min, and mean CF values during RF
applications were 12.2+ 3.9 (range 6.7–23.7) g. A similar value of
mean CF was observed during ablation of the right PVs as compared
with that of the left PVs (12.5+4.3 vs. 11.7+4.7 g, respectively; P ¼
0.14). However, although the difference reaches marginal statistical
significance, the percentage of time during which the CF was ,5 g
was lower during right as compared with left PV ablation (22+ 14
vs. 27+16%, respectively; P ¼ 0.04). The average of the minimum
and maximum CF values were 3.3+ 2.2 (range 0.4–10.7) and
39.4+ 13.6 (range 18–79.6) g, respectively. As shown in Figure 2A,
the average CF during the entire ablation time was quite variable in
different patients. However, 34.7% of the patients had a CF
between 10.01 and 12.5 g and 29.5% between 7.51 and 10 g.
Contact force values were well correlated with FTI (unadjusted
r2 ¼ 0.519, P, 0.001). Figure 2B shows a similarly variable distribu-
tion in different patients of FTI during the entire ablation time.
Figure 3 shows the box and whiskers plot of the CF values during
ablation in the nine centres. Interestingly, in seven of the nine
centres, the range of the median values was minimal, within 4 g,
varying from 12.48 to 8.64.
Effect of contact force on procedural
parameters
The analysis of FTI during ablation showed a median value of 543 gs:
48 patients with FTI below the median value had an average value of
394+100 gs, while the 47 with FTI above had an average value of
Figure 1 CARTOw 3 system screen showing a reconstruction of the LA in posteroanterior view (top left) and left lateral view (top right) with a
decapolar circularmapping catheter and an ablation catheter placed at the ostiumof the left superior PV. The dashboard on the left-hand side shows
the value of CF (16 g), while the arrow on the catheter icon shows theCF direction. The real-time graph of the CF vs. time is also shown (blue line in
the bottom right pane). Surface electrocardiogram and intracavitary electrograms from the coronary sinus catheter and circular mapping catheter
before ablation are also shown (bottom left).
Table 1 Clinical characteristics of the study population
Mean age (years) 58+11 (range 24–82)
Male sex 83%
Left atrium diameter (mm) 40.5+5 (range 33–55)
Left ventricle ejection fraction (%) 58+8 (range 40–65)
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1068+ 520 gs. When these two groups are compared, patients with
FTIbelowthemedian required significantly longerprocedure (158.0+
74.0 vs. 117.0+52.0 min, respectively; P ¼ 0.004) and fluoroscopy
(17.5+13 vs. 11+7.7 min, respectively; P ¼ 0.007) timeswhencom-
pared with patients with FTI above the median value. Moreover, as
shown in Figure 4, patients with a mean CF during ablation .20 g
required significantly shorter procedural time as compared with
patients inwhomCFwas,10 g (92.0+23.0 vs. 160.0+67.0 min, re-
spectively; P ¼ 0.01). In the former group, a non-significant trend
towards shorter fluoroscopy (9.2+5.1 vs. 15.3+10 min, respective-
ly; P ¼ 0.2) and ablation (25+10.1 vs. 36.3+23.7 min; respectively;
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RF Time Procedural Time* Fluoroscopy Time
F<10g F<20g all patients
36.3 25.0 33.8 160 92 138 15.3
9.2
14.3
Figure 4 Radiofrequency (RF) time, fluoroscopy time, and pro-
cedural time in the overall population and in the two subgroups
with CF, 10 g and .20 g, respectively. *P, 0.05
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Complications
Four groin haematomas were observed. No stroke/transient ischae-
mic attack, pericardial effusion, or cardiac tamponadewere reported
within 30 days from the procedure.
Discussion
Main findings
Optimization of electrode–tissue contact during radiofrequency
catheter ablation (RFCA) for PV isolation affects procedural para-
meters by significantly reducing procedural and fluoroscopy times,
without increasing acute complications. Monitoring of catheter–
tissue CF during PV ablation shows awide range of values in different
patients with a significantly shorter time of poor contact during right
as compared with left PV ablation.
Previous studies
First data on CF measuring were reported using a catheter able to
assess catheter–tissue contact by means of optical fibres.7,9 Subse-
quently, two other technologies were developed for clinical use,
based on impedance measurement and magnetic sensors,10,11 re-
spectively. The TOCCATA study investigators9 reported data on
clinical use of a CF sensor for CA of supraventricular tachycardia
and AF. They concluded that CA using real-time CF technology
was safe for the treatment of supraventricular tachycardia and AF:
high CF values may occur not only during catheter manipulation
but also during ablation, suggesting that measuring the CF may
provide additional useful information to the operator for safe cath-
eter manipulation.With the same technology, Kumar et al.12 charac-
terized the CF at different anatomical sites during antral PV isolation
for AF. Monitoring of catheter–tissue CF during RF ablation demon-
strated that there was significant variability in CF both within and
between different PV anatomical sites. For left PVs, the highest CF
areas were the superior and inferior quadrants, while the lowest
CF were the carina and anterior quadrants. For right PVs, the areas
of highest CF values were the anterior and inferior quadrants and
the lowest CF was the carina. Furthermore, CF at any right PV quad-
rantwas consistently higher than the corresponding left PVquadrant,
except at the left superior quadrants where the right and left PVs had
similar CF.
More importantly, data on ablation using CF sensing showed a
strong linear relationship between the number of lesions with low
averageCFor FTI and the time to achieve acutePV isolation, confirm-
ing that catheter–tissue CF is an important determinant of proced-
ural duration and ablation efficacy.8,13 Moreover, acute PV
reconnection was strongly associated with low values of CF and
FTI.12 Availability of real-time CF information during PVI was in this
series associated with a significantly lower acute PV reconnection
rate.12 Recently, Neuzil et al.14 showed that minimum CF and
minimum FTI values are strong predictors of gap formation.
Finally, in a single-centre non-randomized study, Martinek et al.10
found that the CF sensing technology using the Thermocool
SmartTouchTM catheter was able to significantly reduce ablation
and procedural times in PV isolation. Energy deliverywas substantial-
ly reduced by avoiding RF delivery in areas with insufficient tissue–
electrode contact.
Present study
For the first time in amulticentre experience, our data demonstrates,
that optimal CF values duringCAof AF significantly improve the pro-
ceduralparameters. In fact, during ablation, patientswith anFTI above
the median value had shorter procedural and fluoroscopy time and,
similarly, patients with a mean CF value during ablation .20 g had
shorter procedural time.
As already reported by Kumar et al.,12 optimal CFmay be easier to
obtain andmaintain during right as comparedwith left PV ablation. In
our study, the time with poor CF values (,5 g) was significantly
shorter for right than for left PV ablation.
In our study, the mean CF value during ablation is slightly lower
than the one reported in a previous study14 (12.2+ 3.9 vs. 17.2+
3.5 g in our study and the previous one, respectively). The value of
CF during ablation is very close to the value of 10 g, which has been
considered critical for clinical success in the TOCCATA study,15 in
which patients who received ablation with a mean CF below this
value experienced AF recurrences. The difference between our
and previous data is possibly due to different technology used.
Data on follow-up will clarify if the value of 10 g is critical also
using the Thermocool Smart Touch technology. In our study, we
found that patients with a mean CF during ablation .20 g required
significantly shorter procedural time as compared with patients in
whom CF was ,10 g. However, the small sample size and, above
all, the lack of randomization and clinical outcome data does not,
to date, allow conclusive recommendations concerning optimal
CF values. Interestingly, while the mean value of CF during ablation
shows wide inter-patient variability, the range of variation of this
parameter is within 4 g in seven of the nine centres. This leads us
to hypothesize that this value could be more patient-specific
rather than operator-specific. This seems apparently in contrast
with a previous report,9 which showed a wide range of CF values
corresponding to the subjective feedback of ‘good contact’
defined by the operator. However, contrary to the previous
study,9 in our study, the operators had already completed the learn-
ing curve of the use of the CF catheter and were not blind to the CF
values.
Finally, no complication related to ablation and/or catheter ma-
nipulation was observed. Although lack of randomization does not
allow a definitive conclusion, the safety profile of this CF catheter
seems at least comparable with that of the conventional open-
irrigated tip catheter. The low value of fluoroscopy time suggests
that CF sensing could have been useful to minimize the use of fluor-
oscopy to manipulate the catheter without affecting procedural
safety.
Limitations
First, the number of patients enroled in each centre is small and this
might increase the range of data variability, mainly due to the involve-
ment ofmultiple operators.However, this observational prospective
study may provide a representative image of the real-life scenario in
the use of CF sensing for AF ablation.
Secondly, since this was designed as a pilot study to investigate ini-
tially the effect of CF measurement on acute procedural parameters
during RFCA of AF, we did not include data on long-term clinical
outcome.
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Thirdly, CF was computed by averaging values sampled every
50 ms during each RF application; however, bias introduced by abla-
tion strategy (point by point vs. dragging) may not be completely
excluded.
Fourthly, severalparametersmayaffectCF:operators’ attitude and
expertise, use of steerable sheaths, site of transseptal puncture, indi-
vidual anatomy of the LA, rotation of the heart, etc. Moreover, the
direction of the force vector and the thickness of the tissue are
other important variables that could play a major role in creation
of a transmural and durable lesion. Although in our study we did
not evaluate all these variables and their relationship with CF, our
findings show that better the contact is shorter the procedural and
fluoroscopy times are. This is potentially of great clinical relevance.
Conclusion
Contact forcemeasurement is useful in CA aiming at isolation of PVs
for AF. Achievement of a higher FTI and mean CF values during abla-
tion allows reduction of both procedural and fluoroscopy time.
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Appendix
Participating centres (listed in
alphabetical order)
Ospedale Sant’Anna, Ferrara (Matteo Bertini, Lina Marcantoni,
Claudio Pratola); Ospedale Morgagni, Forlı` (Alberto Bandini, Paolo
Golia); Casa di Cura Montevergine, Mercogliano (Francesco Soli-
mene, Giovanni Donnici); Casa di Cura Mediterranea, Napoli
(Assunta Iuliano, Giuseppe Stabile); Policlinico Casilino, Roma (Leo-
nardo Calo`, Ermenegildo De Ruvo, Luigi Sciarra); Ospedale Sandro
Pertini, Roma (Antonello Castro, Marialuisa Loricchio); Azienda
Ospedaliera Santa Maria Nuova, Reggio Emilia (Nicola Bottoni, M
Iori, F Quartieri); Citta` della Salute e della Scienza, Torino (Matteo
Anselmino, Federico Ferraris, Fiorenzo Gaita); Ospedale di Circolo
e Fondazione Macchi, University of Insubria, Varese (Roberto De
Ponti, Raffaella Marazzi, Lorenzo A Doni).
References
1. CammAJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH et al. ESC com-
mittee for practice guidelines. 2012 focused update of the ESC Guidelines for the
management of atrial fibrillation. An update of the 2010 ESCGuidelines for theman-
agement of atrial fibrillation. Europace 2012;14:1385–413.
2. WannLS,CurtisAB, JanuaryCT, EllenbogenKA, Lowe JE, EstesNAM III et al.Writing
on behalf of the 2006 ACC/AHA/ESC Guidelines for the Management of Patients
with Atrial Fibrillation Writing Committee. 2011 ACCF/AHA/HRS focused
update on the management of patients with atrial fibrillation (updating the 2006
guideline): a report of the American College of Cardiology Foundation/American
Heart Association Task Force on Practice Guidelines. Circulation 2011;123:104–23.
3. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA et al. Heart Rhythm
Society Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. 2012
HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation
of Atrial Fibrillation: recommendations for patient selection, procedural techniques,
patientmanagement and follow-up, definitions, endpoints, and research trial design.
Heart Rhythm 2012;9:632–96.
4. Matsuo S, Yamane T, Date T, Inada K, Kanzaki Y, Tokuda M et al. Reduction of AF
recurrence after pulmonary vein isolation by eliminating ATP-induced transient
venous re-conduction. J Cardiovasc Electrophysiol 2007;18:704–8.
5. Bertaglia E, FassiniG, AnselminoM, Stabile G,Grandinetti G, SimoneAD et al.Com-
parison of ThermoCool(w) surround flow catheter versus ThermoCool(w) cath-
eter in achieving persistent electrical isolation of pulmonary veins: a pilot study.
J Cardiovasc Electrophysiol 2013;24:269–73.
6. Stabile G, Scaglione M, Del Greco M, De Ponti R, Bongiorni MG, Zoppo F et al.
Reducedfluoroscopyexposureduring ablationof atrial fibrillationusing anovel elec-
troanatomical navigation system: amulticentre experience.Europace2012;14:60–5.
7. YokoyamaK,NakagawaH, ShahDC, LambertH, LeoG,AebyN et al.Novel contact
force sensor incorporated in irrigated radiofrequency ablation catheter predicts
lesion size and incidence of steam pop and thrombus. Circ Arrhythm Electrophysiol
2008;1:354–62.
8. ThiagalingamA, D’Avila A, Foley L, Guerrero JL, Lambert H, LeoG et al. Importance
of catheter contact force during irrigated radiofrequency ablation: evaluation in a
porcine ex vivo model using a force-sensing catheter. J Cardiovasc Electrophysiol
2010;21:806–11.
9. Kuck KH, Reddy VY, Schmidt B, Natale A, Neuzil P, Saoudi N et al.A novel radiofre-
quency ablation catheter using contact force sensing: TOCCATA study. Heart
Rhythm 2012;9:18–23.
10. Martinek M, Lemes C, Sigmund E, Derdorfer M, Aichinger J, Winter S et al. Clinical
impact of a new open-irrigated radiofrequency catheter with direct force measure-
ment on atrial fibrillation ablation. PACE 2012;35:1312–8.
11. Haldar S, Jarman JW, Panikker S, Jones DG, Salukhe T, Gupta D et al. Contact force
sensing technology identifies sites of inadequate contact and reduces acute pulmon-
ary vein reconnection: a prospective case control study. Int J Cardiol 2012; pii: S0167-
5273(12)01555-0. doi: 10.1016/j.ijcard.2012.11.072 (Epub ahead of print)
12. Kumar S, Morton JB, Lee J, Halloran K, Spence SJ, Gorelik A et al. Prospective char-
acterization of catheter-tissue contact force at different anatomic sites during antral
pulmonary vein isolation. Circ Arrhythm Electrophysiol 2012;5:1124–9.
13. Shah DC, Lambert H, Nakagawa H, Langenkamp A, Aeby N, Leo G. Area under the
real-time contact force curve (force-time integral) predicts radiofrequency lesion
size in an in vitro contractile model. J Cardiovasc Electrophysiol 2010;21:1038–43.
14. Neuzil P, Reddy VY, Kautzner J, Petru J, Wichterle D, Shah D et al. Electrical recon-
nection after pulmonary vein isolation is contingent in contact force during initial
treatment. Results from the EFFICAS I study. Circ Arrhythm Electrophysiol 2013;6:
327–33.
15. ReddyVY, ShahD, Kautzner J, Schmidt B, SaoudiN,HerreraC et al.The relationship
between contact force and clinical outcomeduring radiofrequency catheter ablation
of atrial fibrillation in the TOCCATA study. Heart Rhythm 2012;9:1789–95.
G. Stabile et al.340
